AstraZeneca AB v Apotex Pty Ltd

JurisdictionAustralia Federal only
Neutral Citation[2014] FCAFC 99
Year2014
Date2014
CourtFull Federal Court (Australia)
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
29 cases
  • InterPharma Pty Ltd v Hospira, Inc (No 5)
    • Australia
    • Federal Court
    • 20 Junio 2019
    ...96 IPR 185; 204 FCR 494 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50; 253 CLR 284 AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99; 107 IPR 177; 226 FCR 324 AstraZeneca AB v Apotex Pty Ltd [2015] HCA 30; 257 CLR 356 Austal Ships Sales Pty Ltd v Stena Rederi Aktiebolag [200......
  • Axent Holdings Pty Ltd t/a Axent Global v Compusign Australia Pty Ltd
    • Australia
    • Federal Court
    • 25 Septiembre 2020
    ...2) [2016] FCA 1238; 122 IPR 17 Aspirating IP Limited v Vision Systems Limited [2010] FCA 1061; 88 IPR 52 AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99; 226 FCR 324 AstraZeneca AB v Apotex Pty Ltd [2015] HCA 30; 257 CLR 356 Atlantis Corp Pty Ltd v Schindler (1997) 39 IPR 29 Austal Ships Sa......
  • Boehringer Ingelheim Animal Health USA Inc v Elanco New Zealand
    • Australia
    • Federal Court
    • 25 Noviembre 2021
    ...1 All ER 673; [1962] RPC 55 Aspirating IP Ltd v Vision Systems Ltd [2010] FCA 1061; (2010) 88 IPR 52 AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99; (2014) 226 FCR 324 Blair v Curran [1939] HCA 23; (1939) 62 CLR 464 British Acoustic Films Ltd v Nettlefold Productions Ltd (1935) 53 RPC 221 ......
  • Merck Sharp and Dohme Corporation v Wyeth LLC (No 3)
    • Australia
    • Federal Court
    • 14 Octubre 2020
    ...v Bintang Ltd [1989] FCA 428; 15 IPR 686 Apotex Pty Ltd v Sanofi-Aventis [2009] FCAFC 134; 82 IPR 416 AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99; 226 FCR 324 AstraZeneca AB v Apotex Pty Ltd [2015] HCA 30; 257 CLR 356 Austal Ships Pty Ltd v Stena Rederi Aktiebolag [2005] FCA 805; 66 IPR......
  • Request a trial to view additional results
4 firm's commentaries

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT